EMA adopts new policies on conflicts of interest, access to documents
This article was originally published in SRA
Executive Summary
The European Medicines Agency will publish shortly two long-awaited new policies on how the agency should manage conflicts of interest of its scientific committee experts and how it should allow better public access to EMA documents1.